330 related articles for article (PubMed ID: 11356083)
1. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
2. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
5. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
6. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
10. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
11. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
12. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
13. [Construction, packaging and titration of recombinant adeno-associated virus vectors contaning antitumor genes].
Zhang Y; Leng X; Peng J; He X; Lu J; Weng S; Wang S; Du J
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):564-7. PubMed ID: 12133507
[TBL] [Abstract][Full Text] [Related]
14. [hEPO transfer and expression by a recombinant adeno-associated virus vector].
Wu ZJ; Wu XB; Wang H; Lu B; Dong XY; Hou YD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):176-80. PubMed ID: 12006992
[TBL] [Abstract][Full Text] [Related]
15. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
Allen JM; Halbert CL; Miller AD
Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
[TBL] [Abstract][Full Text] [Related]
16. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction.
Tenenbaum L; Hamdane M; Pouzet M; Avalosse B; Stathopoulos A; Jurysta F; Rosenbaum C; Hanemann CO; Levivier M; Velu T
Gene Ther; 1999 Jun; 6(6):1045-53. PubMed ID: 10455407
[TBL] [Abstract][Full Text] [Related]
17. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes.
Mamounas M; Leavitt M; Yu M; Wong-Staal F
Gene Ther; 1995 Aug; 2(6):429-32. PubMed ID: 7584119
[TBL] [Abstract][Full Text] [Related]
18. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
[TBL] [Abstract][Full Text] [Related]
19. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
20. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
Chadeuf G; Ciron C; Moullier P; Salvetti A
Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
